Inositol Polyphosphate Kinases, Fungal Virulence and Drug Discovery

Area of Science:

• Mycology
• Molecular Biology
• Drug Discovery

Background:

• Opportunistic fungi cause significant global morbidity and mortality, especially in immunocompromised individuals.
• Developing effective antifungal therapies is challenging due to similarities between fungal and host eukaryotic cells, leading to emerging drug resistance.
• *Cryptococcus neoformans* serves as a model organism for studying fungal pathogenesis and identifying new antifungal drug targets.

Purpose of the Study:

• To review the characterization of the phospholipase C (Plc1)/inositol polyphosphate kinase (IPK) pathway in *C. neoformans*.
• To highlight the critical role of pyrophosphorylated inositol pentaphosphate (PP-IP₅ or IP₇) in fungal fitness and virulence.
• To evaluate inositol polyphosphate kinase (IPK) enzymes as potential targets for novel antifungal drug development.

Main Methods:

• Characterization of the Plc1-dependent inositol polyphosphate synthesis pathway in *C. neoformans*.
• Identification of key inositol polyphosphate species, specifically PP-IP₅ (IP₇), essential for fungal survival.
• Assessment of fungal virulence in a mouse model of infection.

Main Results:

• The Plc1/IPK pathway is essential for cellular function and pathogenicity in *C. neoformans*.
• PP-IP₅ (IP₇) was identified as the most critical inositol polyphosphate species for fungal fitness and virulence.
• Inositol polyphosphate kinases (IPKs) are crucial enzymes within this essential pathway.

Conclusions:

• The Plc1/IPK pathway represents a vital mechanism for *C. neoformans* survival and virulence.
• IPK enzymes are promising candidates for the development of urgently needed antifungal drugs.
• Targeting this pathway could offer a new strategy to combat invasive fungal infections.